Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00149188
Status:
COMPLETED
Last Update Posted:
2019-08-05
First Post:
2005-09-07
Brief Title:
Somatuline Autogel Acromegaly SelfPartner Injection Study
Sponsor:
Ipsen
Organization:
Ipsen
Study Overview
Official Title:
A Phase IV Multicentre Open Label Controlled Study to Assess the Ability of Patients With Acromegaly or Their Partners to Administer Somatuline Autogel
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to allow patients with acromegaly or their partners to learn how to successfully inject Somatuline Autogel at home Ability to perform unsupervised injections whilst maintaining adequate disease control will be assessed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None